Table 2 Baseline characteristics of the 170 GC patients with immunohistochemistry data from Sun Yat-sen University Cancer Center
SYSUCC Cohort | H score_high (N = 76) | H score_low (N = 94) | P-value |
|---|---|---|---|
Age | Â | Â | 0.211 |
  < 56 | 33 (43.4%) | 51 (54.3%) |  |
  >  = 56 | 43 (56.6%) | 43 (45.7%) |  |
Stage | 0.121 | ||
 I + II | 52 (68.5%) | 54 (57.4%) |  |
 III + IV | 22 (28.9%) | 40 (42.6%) |  |
 NA | 2 (2.6%) | 0 (0%) |  |
Pathological type | 0.096 | ||
 Moderately differentiated | 21 (27.6%) | 15 (16.0%) |  |
 Poorly differentiated | 55 (72.4%) | 79 (84.0%) |  |
Invasion depth | 0.21 | ||
 Muscle layer and above | 7 (9.2%) | 16 (17.0%) |  |
 Full layer | 69 (90.8%) | 78 (83.0%) |  |
Lymph metastasis | 0.889 | ||
 No | 25 (32.9%) | 33 (35.1%) |  |
 Yes | 51 (67.1%) | 61 (64.9%) |  |
Nerve invasion | 0.86 | ||
 No | 20 (26.3%) | 27 (28.7%) |  |
 Yes | 56 (73.7%) | 67 (71.3%) |  |
Vascular tumor thrombus | 0.647 | ||
 No | 32 (42.1%) | 44 (46.8%) |  |
 Yes | 44 (57.9%) | 50 (53.2%) |  |